Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
CD44 en MET, partners in carcinogenese van CRC
okt 2021 | Maag-darm-leveroncologie